When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. CinCor (CINC) Tanks Due to Dismal Data on Hypertension Drug

    www.aol.com/news/cincor-cinc-tanks-due-dismal...

    CinCor (CINC) plummets as its phase II study, HALO, evaluating its lead candidate baxdrostat for hypertension, fails to meet its primary endpoint.

  3. Baxdrostat - Wikipedia

    en.wikipedia.org/wiki/Baxdrostat

    Baxdrostat is an investigational drug that is being evaluated for the treatment of hypertension. [1] It is an aldosterone synthase inhibitor. [2] [3] References

  4. Matching (statistics) - Wikipedia

    en.wikipedia.org/wiki/Matching_(statistics)

    Matching is a statistical technique that evaluates the effect of a treatment by comparing the treated and the non-treated units in an observational study or quasi-experiment (i.e. when the treatment is not randomly assigned).

  5. Local average treatment effect - Wikipedia

    en.wikipedia.org/wiki/Local_average_treatment_effect

    In the presence of non-compliance, the ATE can no longer be recovered. Instead, what is recovered is the average treatment effect for a certain subpopulation known as the compliers, which is the LATE. When there may exist heterogeneous treatment effects across groups, the LATE is unlikely to be equivalent to the ATE.

  6. Analysis of clinical trials - Wikipedia

    en.wikipedia.org/wiki/Analysis_of_clinical_trials

    However, by restricting the analysis to a selected patient population, it does not show all effects of the new drug. Further, adherence to treatment may be affected by other factors that influence the outcome. Accordingly, per-protocol effects are at risk of bias, whereas the intent-to-treat estimate is not. [7]

  7. Serious adverse event - Wikipedia

    en.wikipedia.org/wiki/Serious_adverse_event

    In drug development, serious adverse event (SAE) is defined as any untoward medical occurrence during a human drug trial that at any dose Results in death; Is life-threatening; Requires inpatient hospitalization or causes prolongation of existing hospitalization; Results in persistent or significant disability/incapacity

  8. File:Baxdrostat.svg - Wikipedia

    en.wikipedia.org/wiki/File:Baxdrostat.svg

    You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made.

  9. Blebbistatin - Wikipedia

    en.wikipedia.org/wiki/Blebbistatin

    Blebbistatin is a relatively strong fluorophore.When dissolved in water, it absorbs at 420 nm and emits at 490 nm however in DMSO or when perfused through cardiac tissue, it absorbs around 430 nm and emits around 560 nm, [22] therefore at high concentrations its fluorescence interferes with GFP imaging or FRET experiments. [7]